granted
on 18 Jun 2024
Last Applicant/ Owned by
885 Third Avenue, 17th Floor
New York
NY
10022
Serial Number
97425841 filed on 24th May 2022
Registration Number
N/A
Correspondent Address
Tomas M. Casalins
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Advertising planning; Advertising services, public relations and marketing services, namely, promoting and marketing the goods and services of others through all public communication means; Business management; Business operation, business administration and office functions Pharmaceutical preparations for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations for t Read More
Advertising planning; Advertising services, public relations and marketing services, namely, promoting and marketing the goods and services of others through all public communication means; Business management; Business operation, business administration and office functions
N/A
N/A
Pharmaceutical preparations for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations for the treatment and prevention of neurodegenerative diseases and disorders; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of pain and neuropathic pain; Pharmaceutical preparations for the treatment and prevention of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of respiratory system diseases and disorders; Pharmaceutical preparations for the treatment and prevention of skin diseases, allergies and rheumatic disorders; Pharmaceutical preparations for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of ophthalmic related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of musculoskeletal related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of hormone disorders and deficiencies; Pharmaceutical preparations for the treatment and prevention of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the treatment and prevention of metabolic, endocrine and kidney related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of nausea and vomiting; Pharmaceutical preparations for the treatment and prevention of AIDS-related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of viral and bacterial infections; Pharmaceutical preparations for the treatment of exposure to toxic agents; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the support and promotion of bone strength and health; Pharmaceutical preparations for use as injectable anesthetics; Pharmaceutical preparations for use as contraceptives; Pharmaceutical preparations for fertility enhancement purposes; Pharmaceutical preparations for use in hormone replacement therapy; Pharmaceutical preparations for inducing labor and facilitating nursing; Pharmaceutical preparations, namely, injectable contraceptives
N/A
N/A
No 97425841
No Service Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
18th Jun 2024 | SOU EXTENSION 2 FILED |
18th Jun 2024 | SOU EXTENSION 2 GRANTED |
18th Jun 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
18th Jun 2024 | SOU TEAS EXTENSION RECEIVED |
01st May 2024 | ASSIGNED TO EXAMINER |
21st Dec 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
19th Dec 2023 | SOU EXTENSION 1 GRANTED |
19th Dec 2023 | SOU EXTENSION 1 FILED |
19th Dec 2023 | SOU TEAS EXTENSION RECEIVED |
13th Nov 2023 | ASSIGNED TO EXAMINER |